Physician profile
Joshua Lyons
NPI 1598159048
$26,444.44
in general payments reported to CMS, 2019-2025
10 companies · $5,886 in 2025
The $5,886 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $11K · 2023: $4,543 · 2024: $4,676 · 2025: $5,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000 · Food and Beverage: $4,337 · Travel and Lodging: $3,759 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
| Food and Beverage | $4,336.64 |
| Travel and Lodging | $3,758.97 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Endoscopy | $17,000.00 | 2022-2025 | |
| Intuitive Surgical, INC. | $2,178.31 | 2022-2025 | |
| Davol INC. | $1,939.87 | 2021-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $1,924.43 | 2023-2024 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $1,911.23 | 2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Boston Scientific Corporation | $673.94 | 2022-2025 | Spyglass Discover |
| Aroa Biosurgery Incorporated | $385.87 | 2023-2025 | |
| Integra Lifesciences Corporation | $185.39 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $139.41 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $105.99 | 2024 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.